Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences
SEATTLE--(BUSINESS WIRE)--Feb 1, 2024--
Stay updated with breaking news from Alpine Immune Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SEATTLE--(BUSINESS WIRE)--Feb 1, 2024--
Alpine Immune Sciences, Inc. , a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today announced that the Company...
Key Insights Institutions' substantial holdings in Alpine Immune Sciences implies that they have significant influence...
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) saw a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 3,980,000 shares, an increase of 32.7% from the December 15th total of 3,000,000 shares. Based on an average daily volume of 788,500 shares, the short-interest […]
Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) were up 3.8% during trading on Wednesday . The stock traded as high as $20.31 and last traded at $20.25. Approximately 255,066 shares were traded during mid-day trading, a decline of 40% from the average daily volume of 425,013 shares. The stock had previously […]